• Home
  • Past Events
    • 2022
      • About
      • Speakers 2022
      • Official Brochure
  • Conference
    • About 2023
    • Agenda
    • Speakers
    • Venues
    • Book Hotel
    • Registration
    • Sponsorship
    • Media Partners
  • Gallery
  • RESCON Europe
  • Contact Us
  • Home
  • Past Events
    • 2022
      • About
      • Speakers 2022
      • Official Brochure
  • Conference
    • About 2023
    • Agenda
    • Speakers
    • Venues
    • Book Hotel
    • Registration
    • Sponsorship
    • Media Partners
  • Gallery
  • RESCON Europe
  • Contact Us
Register now
  • Home
  • Past Events
    • 2022
      • About
      • Speakers 2022
      • Official Brochure
  • Conference
    • About 2023
    • Agenda
    • Speakers
    • Venues
    • Book Hotel
    • Registration
    • Sponsorship
    • Media Partners
  • Gallery
  • RESCON Europe
  • Contact Us
Register now

rescon summit 2022

event information

1 Conference | 25+ Speakers | 100+ Industry Leaders

Inhalation & Respiratory

drug delivery |

Connected Devices

RESCON Summit, the leading event in the respiratory sector and connected devices, took place on October 6th and 7th, 2022 at the 75 Rockefeller Plaza in New York City. Organized by EPM Group, the event attracted 25+ speakers, 100 participants, 20 case studies, and 2 panel discussions.

The RESCON Summit highlighted the latest innovations in aerosol science and the future directions of inhalation drug delivery research. Attendees engaged in discussions about on-body device design and development for large volume delivery, as well as the latest digital applications for wearable devices. The event showcased new trends and cutting-edge technologies in the respiratory sector.

The RESCON Summit started with a pre-conference cocktail reception on October 5th, which gave attendees an opportunity to network and connect with industry peers. On October 6th, the first day of the conference, attendees participated in sessions and panel discussions. The day ended with a Gala Dinner, where attendees continued to network and engage with speakers and other participants.

The second day of the conference, October 7th, continued with more panel discussions and case studies. Attendees learned about the latest trends in the respiratory sector and connected devices, and were able to exchange ideas and insights with industry leaders.

“We are thrilled with the success of the RESCON Summit,” said the organizers of the event. “This year’s conference brought together industry experts and thought leaders to share insights and innovations in the respiratory sector. We look forward to continuing this important conversation and driving innovation in this vital field.”

what was

The key practical points

  • Market introduction of the new Respiratory devices in Europe and USA 
  • Best practices for designing and evaluating smart medical devices 
  • Human factors engineering to improve devices’ use-safety and usability 
  • Developing Biologics for Respiratory Delivery 
  • Case studies on Soft Mist Inhalers (SMI) 
  • Capsules for DPI formulations 
  • Powder dosing and DPI manufacturing 
  • Regulatory landscape for connected drug delivery device 
  • Biocompatibility evaluation of breathing gas pathways 
  • Biocompatibility requirements for inhalation drug-device combination products 
  • Advantages and challenges of inhaled drug delivery 
  • Respiratory Therapy for Managing Chronic Cough 
  • Innovative solution of an eFlow technology nebulizer 
  • Innovations in inhalation drug delivery 
  • Performance of Orbital device and formulation combination 
  • Advanced Drug Delivery Systems for Patient Centric Medication 
  • Environmental sustainability challenge to the inhalation devices industry 
  • Liquid Crystal Polymers 
  • Auto-injector for Asthma exacerbations

who

attended RESCOn 2022

Members of board, C-level, Senior Vice Presidents, Vice Presidents, Directors and Heads of departments from the following companies:

  • AbbVie
  • ACG
  • Akita Biosciences
  • Amgen
  • Aptar Pharma
  • Astrazeneca
  • Avient Corporation
  • Berry Global
  • Beyond Conception
  • Boehringer Ingelheim
  • Catalent Pharma Solutions
  • Celanese
  • Crossject AS
  • CSL Behring
  • Emergo by UL
  • Eurofins
  • FEND
  • Fluidda
  • Gerresheimer
  • Harro Höfliger
  • InhaTarget Therapeutics
  • Intertek Melbourn
  • Labcorp
  • MannKind Corporation
  • Merck
  • Merxin Ltd
  • MUNIT AS
  • Nanopharm, an Aptar Company
  • PARI Medical Holding GmbH
  • PAVmed Inc
  • Presspart Manufacturing
  • Proveris Scientific Corporation
  • PulmoSIM Therapeutics
  • Quench Medical
  • Resyca
  • Sanofi
  • Smithers
  • Solvias AG
  • St. John’s University
  • United Therapeutics
  • UAMS
  • Veranex
  • Vertex Pharmaceutical
  • Viatris
  • Vivo Capital

Meet

The Speakers 2022

Irene Rossi

Head of New Modalities Pharmaceutical Development at Nanopharm, an Aptar Company

Michael Castagna

Chief Executive Officer at MannKind Corporation

Nitesh Kunda

Assistant Professor, Industrial Pharmacy & Pharmaceutics at St. John’s University

Marian Asch

Sales Manager Inhalation Technologies at Harro Höfliger

Vivek Gupta

Associate Professor, and Scientific Founder at St. John

Felix Weiland

Director Device Technology at Boehringer Ingelheim microParts

Carla Vozone

VP Inhalation Strategy, Innovation and Partnerships at Catalent Pharma Solutions

Deepika Lakhani

Vice President of Regulatory & Quality at PAVmed Inc.

David Edwards

Founder at FEND

Mark Parry

Technical Director at Intertek Melbourn

Yvonne Limpens

Managing Human Factors Specialist at Emergo by UL

Emily Resseguie

Inhalation Toxicologist at Labcorp

Bernhard Müllinger

General Manager, COO at Resyca

Mahendra Shah

Senior Fellow at Vivo Capital

Jan De Backer

CEO at Fluidda

Carola Fuchs

Director e-Health Solutions at PARI Medical Holding GmbH

Justin Kalafat

Head of International Scientific Business Development at ACG

Charles Ducker

Principal Chemist/Group Leader, Extractables and Leachables at Eurofins

Marco Franza

Sales & Director Inhalation at Berry Global

Donald Zinn

VP US Business at Crossject SA

Don Smith

Inventor and Founder at 1nhaler

Holger Krenz

Global Vice President Business Development High Value Products Tubular Glass at Gerresheimer

Valerie Thomas

Sr. Principal Scientist- Nonclinical Drug Safety at Merck & Co.

Ingo Waschulewski

International Business Development & Sales Manager at Gerresheimer

Sponsored by


register now

rescon summit

28-29 September 2023 @Manhattan, New York, USA

Starts from

$1850

  • Workshops & Sessions
  • Networking events
  • Exclusive Venue
  • Pre-Cocktail Reception
  • Luxurious Gala Dinner
Register now

register until APR'23 and save 20%

© 2017 Copyright All Rights Reserved | Powered by EPM Group

Terms & Conditions | Privacy Policy